David M. Epstein

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Suite 150, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Thomas Eastling, as attorney-in-fact for David M. Epstein
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David M. Epstein

Form 4 holding Officer Title: President and Chief Executive Officer, Director

Black Diamond Therapeutics, Inc.

Security class
Common Stock
Shares / value
671,423
Estimated value
$1,832,985
Report date
27 Jun 2023
Price
$2.73
Ownership
Direct
Form 4 holding Officer Title: President and Chief Executive Officer, Director

Black Diamond Therapeutics, Inc.

Security class
Common Stock
Shares / value
16,579
Estimated value
$45,261
Report date
27 Jun 2023
Price
$2.73
Ownership
Indirect

Insider Reports Filed by David M. Epstein

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .